176 related articles for article (PubMed ID: 22382876)
21. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
Aarts WM; Schlom J; Hodge JW
Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
[TBL] [Abstract][Full Text] [Related]
22. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM
Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay.
Nielsen SL; Sørensen I; Andersen HK
J Clin Microbiol; 1988 Apr; 26(4):654-61. PubMed ID: 2835388
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.
Fu SL; Pierre J; Smith-Norowitz TA; Hagler M; Bowne W; Pincus MR; Mueller CM; Zenilman ME; Bluth MH
Clin Exp Immunol; 2008 Sep; 153(3):401-9. PubMed ID: 18803764
[TBL] [Abstract][Full Text] [Related]
25. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
[TBL] [Abstract][Full Text] [Related]
26. T cell dependent differentiation of human B cells: direct switch from IgM to IgE, and sequential switch from IgM via IgG to IgA production.
Brinkmann V; Müller S; Heusser CH
Mol Immunol; 1992 Oct; 29(10):1159-64. PubMed ID: 1528190
[TBL] [Abstract][Full Text] [Related]
27. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Kim-Schulze S; Kim HS; Wainstein A; Kim DW; Yang WC; Moroziewicz D; Mong PY; Bereta M; Taback B; Wang Q; Kaufman HL
J Immunol; 2008 Dec; 181(11):8112-9. PubMed ID: 19018004
[TBL] [Abstract][Full Text] [Related]
28. IL-4 supplemented B-cell cultures of allergic children show reduced IgA and IgG production in response to additional stimulation with IL-10.
Nies JH; Bär C; Schlenvoigt G; Fahlbusch B; Zwacka G; Markert UR
J Investig Allergol Clin Immunol; 2002; 12(2):99-106. PubMed ID: 12371537
[TBL] [Abstract][Full Text] [Related]
29. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
Braster R; O'Toole T; van Egmond M
Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
Lesterhuis WJ; De Vries IJ; Schreibelt G; Schuurhuis DH; Aarntzen EH; De Boer A; Scharenborg NM; Van De Rakt M; Hesselink EJ; Figdor CG; Adema GJ; Punt CJ
Anticancer Res; 2010 Dec; 30(12):5091-7. PubMed ID: 21187495
[TBL] [Abstract][Full Text] [Related]
31. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
32. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.
Durrant LG; Denton GW; Jacobs E; Mee M; Moss R; Austin EB; Baldwin RW; Hardcastle JD; Robins RA
Int J Cancer; 1992 Mar; 50(5):811-6. PubMed ID: 1544714
[TBL] [Abstract][Full Text] [Related]
33. scFv6.C4 DNA vaccine with fragment C of Tetanus toxin increases protective immunity against CEA-expressing tumor.
Zanetti BF; Ferreira CP; de Vasconcelos JRC; Han SW
Gene Ther; 2019 Nov; 26(10-11):441-454. PubMed ID: 30770895
[TBL] [Abstract][Full Text] [Related]
34. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
[TBL] [Abstract][Full Text] [Related]
35. Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.
Liu KJ; Wang CC; Chen LT; Cheng AL; Lin DT; Wu YC; Yu WL; Hung YM; Yang HY; Juang SH; Whang-Peng J
Clin Cancer Res; 2004 Apr; 10(8):2645-51. PubMed ID: 15102666
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
37. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.
Morse MA; Niedzwiecki D; Marshall JL; Garrett C; Chang DZ; Aklilu M; Crocenzi TS; Cole DJ; Dessureault S; Hobeika AC; Osada T; Onaitis M; Clary BM; Hsu D; Devi GR; Bulusu A; Annechiarico RP; Chadaram V; Clay TM; Lyerly HK
Ann Surg; 2013 Dec; 258(6):879-86. PubMed ID: 23657083
[TBL] [Abstract][Full Text] [Related]
38. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
Park JS; Kim HS; Park HM; Kim CH; Kim TG
Vaccine; 2011 Nov; 29(47):8642-8. PubMed ID: 21945963
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.
Ragnhammar P; Masucci G; Frödin JE; Hjelm AL; Mellstedt H
Cancer Immunol Immunother; 1992; 35(3):158-64. PubMed ID: 1638551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
